Tags: Add Tags
  1. anonymous

    anonymous Guest

    while the main culprit in MFG is wholly incompetent and has been over her head for a decade, at least she will not be wearing stripes and sleeping on a concrete bed like Chuckie their slick CSO. Dude perfected selling ice to Eskimos. Problem is he overstated and exaggerated science to obtain investor dollars. As the class action suits unfold ... his lies along path and perks at data when everyone else were blinded until DMC called study for futility will = JAIL TIME 4 CHUCKIE. Good luck with Bubba Chuckie. He loves slick talking smaller boys.
     

  2. anonymous

    anonymous Guest

    CMO resigns and there were no disagreements amongst leadership?!! Laughsblevand yet again another false, misleading statement from this rookie leadership team.

    Vegas placed odds 4-3 the slick haired, slick talking CSO is once again trying to manipulate the data. He's been the central problem for over a decade at this Company and somehow despite the failures is still calling the shots. Per previous post, he's going to look good in Stripes and "Bubba" is going to enjoy having a new girlfriend soon.

    Hahahaha!!!!!
     
  3. SilentHunter

    SilentHunter new user

    Joined:
    Sep 19, 2016
    Messages:
    55
    Likes Received:
    0
    Hi guys. Thought I'd write in from my prison cell. It's really not so bad here - we get bread and water 3 times a day, and an hour of exercise in the yard every other day.

    Well, that was for anonymous's benefit. As I mentioned before, I'm not an insider, but I did lose a bunch of money on this company. I sold on 2/22 at 1.60 at the opening bell, which was a good decision because the stock kept going down from there.

    Now, they have released an public update on 4/18 that basically says there may be a tail of the curve effect with this drug and there even still may be a clinical benefit. That's the good news. The bad news may be that they need to raise more money (biotech companies always need to). Hello stock dilution. But, with such a low stock price, it may be possible that somebody could buy them out. (Hello premium on the stock).

    So, it's basically a 50/50 proposition. Actually, slightly better odds that you get playing roulette in a casino.

    I'm not suggesting that anybody do anything, but thought I'd mention this.
     
  4. anonymous

    anonymous Guest

    SH - you lost big time because you were (are) an insider. Even if you were being honest about your investment (doubtful) vs direct employment, there is simply no way you could be as stupid as you suggest to buy the post-hoc analysis bullshit and continued lies from slick Chuckie regarding the immune response being linked to AGS003, the never planned or utilized tertile analysis, etc?!!! You may think you are coy but c'mon now - are you really that stupid?

    Regardless, slides 9,28 and 30 from the company's release of data this week simply informs every rational, intelligent person that Argos is as dead as this approach.

    Since you are a former or currrent employee, when you go to jail with Chuckie, maybe you can share a cement bed and become even better acquainted. The 2 of you deserve one another. Have fun in Stripes!!
     
  5. anonymous

    anonymous Guest

    oh my ... just realized that one of the folks out here was a former, incredibly jealous and even more incompetent QC manager from Argos. Thank God Duke is large and doesn't require competence.

    LL is fitting as it means "double loser" ...

    Your comments on the high quality, incredibly competent head of Quality are clearly the result of your intense jealousy and envy.

    LL - you are simply as much of a tool as SH. Former employees who simply screwed things up royally!!

    BMFA!!
     
  6. anonymous

    anonymous Guest

    stong post
     
  7. anonymous

    anonymous Guest

    really
     
  8. anonymous

    anonymous Guest

    What they meant was "strong" post. IMO that is spot on. LL was as incompetent as they come at the former company known as Argos. Assuming the fire sale happens soon. Not many people left, and certainly limited to no talent at any level.

    Thinking of the online discount retailer from the UK named Argos, perhaps they can start to sell the equipment from their sites and their warehouse (eg., that new manufacturing center that never was) to pay back their investors. Maybe slick Chuckie will preside as the auctioneer. rumor has it he's truly a jack of all trades and a master of none.
     
  9. anonymous

    anonymous Guest

    Good points.
     
  10. anonymous

    anonymous Guest

    Why so quiet out there?
     
  11. anonymous

    anonymous Guest

    It is the sound of a poorly run company gathering dust at 31 cents a share.


    Somebody please, just put it out if its misery.
     
  12. SilentHunter

    SilentHunter new user

    Joined:
    Sep 19, 2016
    Messages:
    55
    Likes Received:
    0
    Nothing to do here except wait. The treatment did not demonstrate improvement within the expected time frame originally set up with the FDA. Argos says that improvement will be shown in the long term survivors. They received a 6 million dollar loan.

    I don't own any shares in this any more but would buy if they did a reverse spilt (bringing the price to $5 a share or something) AND then a bunch of folks shorted the stock. That scenario sets up a perfect storm where any type of good news at all would set up a short squeeze like you couldn't believe, which would make the price sky rocket. Nothing like that has happened so I'm staying out.
     
  13. anonymous

    anonymous Guest

    Argos is a wet dream - no product and no future. JA is milking every possible dime from the Russians and lining his pockets.

    The jig is up! Argos is a scam! QA is headed by and illegal alien.
     
  14. anonymous

    anonymous Guest

    strong post
     
  15. anonymous

    anonymous Guest

    really
     
  16. anonymous

    anonymous Guest

    Thank goodness Silent Hunter (aka former employee) was fired and no longer has any shares to exercise (well, even if he did, they'd be under water - hahahaha!!!).

    On a more pertinent note, Lee Landis needs to stop posting hate messages out here. She was not only incompetent in her QC role, but extremely jealous of the talent brought into Argos 3-5 years ago to overcome hers and others incompetence in quality.

    LL should stick to running microbiology tests at Duke. Better suited.

    Reality is that the head of QA at Argos is top notch and too talented for this shitty company. She'll land somewhere better than a microbiology lab, LL. Stop the bullshit hate.
     
  17. anonymous

    anonymous Guest

     
  18. anonymous

    anonymous Guest

    I know no one is involved with these threads anymore but I must say that "IQs seemed to drop" dramatically after I left Argos in 2016. Biotech is a big gamble going from a 20+ single arm phase 2 to a huge randomized pivotal study. Small numbers are deceiving in a Phase 2 and Argos lost big in the Phase 3. Whoever this dude Silent Hunter is has been full of shit along the way. Good he has disappeared along with Argos. All of you need the Krell brain boost from what I have read retrospectively. No reply needed from anyone. Just a statement to all of you idiots.
     
  19. SilentHunter

    SilentHunter new user

    Joined:
    Sep 19, 2016
    Messages:
    55
    Likes Received:
    0
    So I said there was nothing to do except wait. Not particularly complicated is it? We all know the score here, the next piece of bad news is probably the last. Argos says their drug is showing a benefit. We'll see. I don't own any stock. I think this may go down to 10 cents a share. Doubt we'll get any news over the holidays. I'll take a fresh look at this on Jan 1 and evaluate then.
     
  20. anonymous

    anonymous Guest

    bring on a new year